Up to 2 WeeksUsually despatched within 2 weeks
We do not currently have a description for this product.
HAEMATOLOGY1 Natural history of inhibitor in severe haemophilia A and B: incidence and prevalence Jeanne Lusher (USA) 2 Characterisation of inhibitors in congenital haemophilia Kathelijne Peerlinck and Marc Jacquemin (Belgium) 3 Incidence and prevalence of inhibitors and type of blood product in haemophilia A Christine Lee and Thynn Thynn Yee (UK)4 Genetic basis of inhibitor development in severe haemophilia A and B Edward Tuddenham (UK) and Johannes Oldenburg (Germany) MANAGEMENT OF TREATMENT 5 Therapeutic products: human FVIII, porcine FVIII, prothrombin complex concentrates, activated prothrombin complex concentrates and recombinant FVIIa Thierry Lambert (France) 6 Methods: plasmapheresis and protein A immuno-adsorption Eric Berntorp (Sweden)7 Venous access in children with inhibitors Rolf Ljund (Sweden) IMMUNETOLERANCE 8 Immunetolerance: high dose regimen Hans Brackmann and Thomas Wallny (Germany) (To be agreed) 9 Immunetolerance: low dose regimen Eveline Mauser-Bunschotten (Netherlands) 10 Immunotolerance and choice of concentrates Wolfgang Kreutz (Germany) 11 Immunetolerance regimen: the North America registry (To be agreed) Donna DiMichele (USA)MEDICAL MANAGEMENT OF BLEEDING EPISODES 12 Treatment of bleeding episodes in children Joan Tusell (Spain) 13 General medical management of bleeding episodes: haemarthroses, muscle haematoma, mucocutaneous bleed, haematuria Manuel Quintana (Spain)14 Life- and limb-threatening bleeding episodes and intracranial bleeds Sam Schulman (Sweden)INHIBITORS IN HAEMOPHILIA B15 Inhibitors in haemophilia B patients India Warrier (USA)16 Inhibitors in mild/moderate haemophilia Charles Hay (UK) 17 Acquired inhibitors to FVIII Craig Kessler (USA) MUSCULOSKELETAL ISSUES 18 Pathogenesis of musculoskeletal complications of haemophilia E C Rodriguez-Merchan (Spain) 19 Orthopaedic management of haemarthroses E C Rodriguez-Merchan (Spain)20 Synoviorthesis with Rifampicin Horacio Caviglia (Argentina) and F Fernandez-Palazzi (Venezuela)21 Radiosynoviorthesis Eric Berntorp (Sweden)22 Musculoskeletal MRI Rachel Nuss and Jerome Wiedel (USA) 23 Iliopsoas haematomas and limb compartment syndromes Michael Heim (Israel) 24 Pseudotumours Marvin Gilbert (USA) 25 Haemophilia patients with inhibitors: a rheumatologist's point of view John York (Australia) 26 Rehabilitation Felipe Querol and Jose Aznar (Spain) 27 Physiotherapy Karen Beeton (UK) 28 Elective orthopaedic surgery in patients with high responding inhibitors-Ivan Hvid, J Soballe and J Ingerslev (Denmark) GENERAL SURGERY 29 General and emergency surgery in patients with high responding inhibitors Owen Smith & Barry White (Ireland) 30 Dental extractions Uri Martinowitz (Israel)PSYCHOSOCIAL ISSUES 31 Psychological issues Pilar Arranz (Spain) 32 GENERAL STRATEGY FOR MANAGEMENT OF INHIBITOR PATIENTS Inga Scharrer (Germany)
Number Of Pages:
- ID: 9780632064779
- Saver Delivery: Yes
- 1st Class Delivery: Yes
- Courier Delivery: Yes
- Store Delivery: Yes
Prices are for internet purchases only. Prices and availability in WHSmith Stores may vary significantly
© Copyright 2013 - 2018 WHSmith and its suppliers.
WHSmith High Street Limited Greenbridge Road, Swindon, Wiltshire, United Kingdom, SN3 3LD, VAT GB238 5548 36